Bleznick v. DePaolo

CourtUnited States Bankruptcy Court, D. New Jersey
DecidedMarch 10, 2023
Docket22-01159
StatusUnknown

This text of Bleznick v. DePaolo (Bleznick v. DePaolo) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bleznick v. DePaolo, (N.J. 2023).

Opinion

= ee % ue! 2 os if # Ye, ly □ Order Filed on March 10, 2023 by Clerk U.S. Bankruptcy Court District of New Jersey

UNITED STATES BANKRUPTCY COURT DISTRICT OF NEW JERSEY

In Re: Case No.: 22-12238 GREGORY JOHN DePAOLO, Chapter: Judge: John K. Sherwood Debtor.

HOWARD BLEZNICK and Plaintiffs, Vs. GREGORY JOHN DePAOLO, Defendant.

OPINION RE: DEFENDANT’S MOTION TO DISMISS Howard Bleznick and Daniel Albizati (“Plaintiffs”) brought this adversary proceeding against Gregory DePaolo (“Debtor”) seeking to prevent the Debtor from discharging his debts in this Chapter 7 case. The Plaintiffs seek this relief based on the Debtor’s alleged misconduct in the Chapter 11 case of his pharmacy business, Belzo LLC d/b/a Rockaway Pharmacy & Compounding (“Belzo’”), and his failure to disclose assets in his personal Chapter 7 case.

C aption of Order: OPINION RE: DEFENDANT’S MOTION TO DISMISS

The Debtor was the principal and sole member of Belzo. In connection with Belzo’s bankruptcy case, the Plaintiffs allege the Debtor siphoned money from the business through member draws, suppressed the value of a part of the business, refused to market the business, and discouraged potential buyers. The Plaintiffs allege that the Debtor tried to sell a part of the business to a friend at a depressed price and retain control of the business. The Debtor argues that the amended complaint should be dismissed because the proposed sale did not happen and, ultimately, Belzo proposed a Chapter 11 Subchapter V plan (“Plan”) that was confirmed by this Court without objection by the Plaintiffs. Though some of the Debtor’s arguments are compelling, the Court must construe the amended complaint in the light most favorable to the Plaintiffs. Viewed in this manner, sufficient facts have been alleged to show that the Debtor may have committed acts as the principal of Belzo in its Chapter 11 case that could be a basis for the denial of a discharge in the Debtor’s individual Chapter 7 case. The Plaintiffs also seek to deny the Debtor’s discharge based on his acts in his personal Chapter 7 case. They have alleged, based on a review of the Debtor’s income and expenses in his Chapter 7 schedules, that a substantial amount (approximately $46,000) of pre-petition income should have been in the Debtor’s accounts when he filed his Chapter 7 case but was not. Thus, it

is plausible that the Debtor may have made a false account, failed to explain a loss of assets, and concealed financial records and assets in his personal Chapter 7 case. For those reasons, the motion to dismiss will be denied. JURISDICTION This Court has jurisdiction over this adversary proceeding pursuant to 28 U.S.C. §§ 1334(b), 157(a), and the Standing Order of Reference from the United States District Court for C aption of Order: OPINION RE: DEFENDANT’S MOTION TO DISMISS

the District of New Jersey. This matter is a core proceeding pursuant 28 U.S.C. § 157(b)(2)(J). Venue is proper under 28 U.S.C. §§ 1408 and 1409(a). FACTS & PROCEDURAL HISTORY The Debtor owned and operated Belzo, a retail pharmacy and compounding business. [ECF No. 11, ¶¶ 10-11].1 The Debtor’s compounding business consisted of preparing specialized medications based on doctors’ or veterinarians’ orders. [ECF No. 11-2, Ex. A, pp. 10-12]. On July 18, 2014, the Debtor acquired the pharmacy and compounding business for $800,000 from Alblez, Inc. (“Alblez”). Belzo entered into and the Debtor personally guaranteed a $800,000 promissory note with Alblez, which was owned by the Plaintiffs. Alblez dissolved in 2016 and the note was transferred to the Plaintiffs. [ECF No. 11, ¶¶ 4-6]. The Plaintiffs filed a proof of claim in this case for $481,960.41, the balance due under the note. [Debtor Case, Claim No. 12- 1]. In December 2018, the Debtor purchased another compounding business for $75,000. [ECF No. 11, ¶ 46].

On October 5, 2020, Belzo filed its Chapter 11 bankruptcy case. [ECF No. 11, ¶ 10]. On January 14, 2021, the Court authorized Belzo to enter into an agreement with New Jersey CVS Pharmacy, L.L.C., to sell its retail business (but not the compounding business). On February 19, 2021, the Court approved the sale of the retail business to CVS, which generated net proceeds of $408,364.81. [ECF No. 11, ¶¶ 15-16]. The proceeds were used to fully pay off one of Belzo’s

1 Throughout the decision, the Court will cite to three different dockets. When no docket is indicated, the Court is citing to the docket in this adversary proceeding. Otherwise, the Court will refer to the docket in case no. 20-21322 as “Belzo Case” and the docket in case no. 22-12238 as “Debtor Case.” C aption of Order: OPINION RE: DEFENDANT’S MOTION TO DISMISS

largest secured creditors, Cardinal Health 110 LLC, and make payments to the United States Trustee. [Belzo Case, ECF No. 110, pp. 7-8, 13]. On February 17, 2021, Belzo filed a motion to sell the compounding business for $75,000 to Curtis Appleby (“Appleby”) with whom the Debtor had a long-standing personal relationship. [ECF No. 11, ¶¶ 17, 32]. Had the sale closed, the Debtor would have remained employed by the compounding business, managed the business with Appleby, and received a salary of $90,000 per year. [ECF No. 11, ¶ 32]. On March 16, 2021, the Plaintiffs filed opposition to Belzo’s proposed sale of the compounding business. [ECF No. 11, ¶ 19]. The Plaintiffs claimed that $200,000 of the $800,000 total sale price in the July 2014 sale was attributable to the compounding business and that the Debtor’s purchase of an additional compounding business for $75,000 in December 2018, would put the value of the Debtor’s compounding business in the neighborhood of $275,000.2 [Belzo Case, ECF No. 121-1, ¶¶ 5-8]. Additionally, the Plaintiffs questioned how the

Debtor arrived at the $75,000 valuation given that Belzo was generating $300,000 in sales per year. [ECF No. 11, ¶ 48]. The Plaintiffs also claimed the Debtor was acting in bad faith by not marketing the compounding business to other buyers. According to the Plaintiffs, they unsuccessfully attempted to get information from the Debtor in order to make an offer to purchase the

2The July 2014 contract for sale between the Plaintiffs and the Debtor did not specify that $200,000 of the total $800,000 sale price was attributable to the compounding business. [Belzo Case, ECF No. 123, Ex. B]. C aption of Order: OPINION RE: DEFENDANT’S MOTION TO DISMISS

compounding business.3 [Belzo Case, ECF No. 121-1, ¶ 17]. In addition, the Plaintiffs alleged that the Debtor directed his customers to a new compounding business when he, without Court approval, posted a bulletin on the compounding business’s social media page announcing the closing of Rockaway Pharmacy and Compounding and the transfer of all prescriptions to the “new compounding pharmacy . . . called DePaolo Compounding.” [Belzo Case, ECF No. 121-1, ¶ 20]. The Debtor posted the announcement on February 25, 2021, before the hearing on the approval of the sale to Appleby. [ECF No. 11, ¶ 34]. On March 18, 2021, Belzo disclosed that it received a competing bid for the compounding business from Realvio REI LLC (“Realvio”). [ECF No. 11, ¶ 22]. In response to Realvio’s offer, Appleby responded with a competing offer. [Belzo Case, ECF No. 124, Ex. E]. A short time later, Belzo executed another purchase agreement with Appleby for an increased price. [Belzo Case, ECF No. 124, Ex. E]. On March 19, 2021, the Plaintiffs filed a cross-motion for an order appointing a Chapter

11 trustee.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vargo Ex Rel. Vargo v. Plum Borough
376 F. App'x 212 (Third Circuit, 2010)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
In Re Longview Aluminum, L.L.C.
657 F.3d 507 (Seventh Circuit, 2011)
CoreStates Bank, N.A. v. Huls America, Inc.
176 F.3d 187 (Third Circuit, 1999)
Grumbine v. Azeglio (In Re Azeglio)
422 B.R. 490 (D. New Jersey, 2010)
McLaughlin v. Rova Farms, Inc.
266 A.2d 284 (Supreme Court of New Jersey, 1970)
State v. Brown
927 A.2d 569 (New Jersey Superior Court App Division, 2007)
Thomas Foglia v. Renal Ventures Management
754 F.3d 153 (Third Circuit, 2014)
Robin Baptiste v. Bethlehem Landfill Company
965 F.3d 214 (Third Circuit, 2020)
Energy Future Holdings Corp. v.
990 F.3d 728 (Third Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Bleznick v. DePaolo, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bleznick-v-depaolo-njb-2023.